Genmab A+s
Patents = 107
Trademarks = 33
Forward Citations = 1,020
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
271 inventors (with patents filed for the assignee):
Genmab is an international biotechnology company that specializes in the research, development, and commercialization of antibody-based therapies to treat cancer. The company focuses on creating innovative and differentiated antibody products to address unmet medical needs. With a diverse pipeline and a track record of successful collaborations, Genmab is committed to improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com